Bioventus Inc

CUSIP 09075A108COM CL ABVSQ1 2026

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

29.3%

Max % of class reported

Institutional Holders

152

13F filers (latest quarter)

19 filings · latest Feb 13, 2026

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Feb 13, 2026	Nantahala Capital Management, LLC	13G/A	9.0%	6.05M	SEC
2	Aug 14, 2025	Nantahala Capital Management, LLC	13G/A	8.0%	5.28M	SEC
3	Nov 14, 2024	Nantahala Capital Management, LLC	13G/A	6.7%	4.35M	SEC
4	Nov 8, 2024	Spindletop Healthcare Capital, L.P.	13G/A	—	—	SEC
5	Jul 15, 2024	Amp-Cf Holdings, LLC	13G/A	—	—	SEC
6	Feb 14, 2024	Nantahala Capital Management, LLC	13G/A	9.5%	5.98M	SEC
7	Feb 6, 2024	Amp-Cf Holdings, LLC	13G/A	5.2%	3.26M	SEC
8	Jan 22, 2024	Ew Healthcare Partners Acquisition Fund, L.P.	13G/A	19.2%	12.10M	SEC
9	Jun 16, 2023	Juniper Investment Company, LLC	13D/A	7.4%	4.62M	SEC
10	May 24, 2023	Juniper Investment Company, LLC	13D/A	7.4%	4.62M	SEC

See the full Schedule 13D/13G history for Bioventus Inc.

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Essex Woodlands Management, Inc.	13.02M	$118.88M
2	Juniper Investment Company, LLC	6.94M	$63.36M
3	Nantahala Capital Management, LLC	6.12M	$55.90M
4	Blackrock, Inc.	3.13M	$28.61M
5	Royce & Associates LP	1.54M	$14.07M
6	Geode Capital Management, LLC	1.17M	$10.67M
7	State Street Corp	988.4K	$9.02M
8	Dimensional Fund Advisors LP	873.1K	$7.97M
9	Hillsdale Investment Management Inc.	671.1K	$6.13M
10	Oberweis Asset Management Inc/	628.1K	$5.73M